Next-Generation Sequencing Market to show Significant Growth at a CAGR of 18.05 % through 2020-2025|Key Players- Agilent Technologies, Inc., Eurofins Scientific, Genome Life Sciences, GenScript, Illumina, Inc. and More

Market Analysis

Global Next Generation Sequencing Market Size is expected to exhibit significant growth over the forecast period. The NGS Market Growth is projected to register a CAGR of 18.05% over the forecast period to reach USD 20,347.45 Million by 2025.

NGS Technology is that helps to determine the sequence of DNA molecules that have a total size significantly larger than 1 million base pairs. The technology has revolutionized biological sciences with its ultra-high throughput, scalability, and speed that assists researchers to carry out a wide range of applications and study biological systems.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6354

Factors such as the rising technological advancements, increasing applications of NGS, and growth in genome mapping programs are expected to drive the market growth. Furthermore, the increasing demand for personalized medicine and high growth in the development of companion diagnostics is also expected to fuel market growth.

However, lack of awareness, ethical issues associated with whole-genome sequencing and difficulty in the management of large data are expected to hamper the market growth.

Next-Generation Sequencing Market Segmentation

The Global Next-Generation Sequencing Market has been segmented into Technology, Workflow, Application, End User, and Region.

Based on technology, the global next-generation sequencing market has been divided into targeted sequencing & resequencing, whole-genome sequencing, and whole-exome sequencing. The targeted sequencing & resequencing segment has been further divided into DNA-based targeted sequencing & resequencing and RNA-based targeted sequencing & resequencing.

Based on workflow, the global next-generation sequencing market has been divided into pre-sequencing, sequencing, and data analysis. The pre-sequencing segment has been further segmented into NGS library preparation kits, NGS-semi-automated library preparation kits, NGS automated library preparation kits, and clonal amplification. The data analysis segment is further segmented into NGS primary data analysis, NGS secondary data analysis, and NGS tertiary data analysis.

The global next-generation sequencing market, by applications, has been segmented into oncology, clinical investigation, reproductive health, human leukocyte antigen typing or immune system monitoring, metagenomics, epidemiology, and drug development, agrigenomics & forensics, consumer genomics, and others. The oncology segment has been further divided into diagnostics & screening, oncology screening, companion diagnostics, and others. The clinical investigation segment has been further divided into infectious diseases, inherited diseases, idiopathic diseases, non-communicable diseases, and others. The reproductive health segment has been further divided into non-invasive prenatal testing, pre-implantation genetic testing, newborn or genetic screening, and single-gene analysis.

The global next-generation sequencing market, by end-user, has been segmented into hospitals & clinics, diagnostic laboratories, pharmaceutical and biotechnology companies, and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The next-generation sequencing market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European next generation sequencing market has been segmented into Western Europe and Eastern Europe. The market in Western Europe has further been classified as France, Germany, Spain, the UK, Italy, and the rest of Western Europe.

The next generation sequencing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Middle East & Africa next generation sequencing market has been segmented into the Middle East and Africa.

Next Generation Sequencing Market Companies

Agilent Technologies, Inc. (US), Eurofins Scientific (Luxembourg), Genome Life Sciences (India), GenScript (US), Illumina, Inc. (US), Thermo Fisher Scientific (US), Qiagen (Germany), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Pacific Biosciences of California, Inc. (US), Xcelris Genomics (India), Macrogen, Inc. (South Korea), BGI (US), Charles River (US), and Oxford Nanopore Technologies (UK) are some of the key players operating in the global next generation sequencing market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/next-generation-sequencing-market-6354

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

This release was published on openPR.